Specialty Pharmaceutical Company with a Focus in Pain and Addiction

Apr 23, 2018 /

Data provided by Nasdaq. Minimum 15 minutes delayed.

BioDelivery Sciences ("BDSI"®) is a specialty pharmaceutical company with a focus in the areas of pain management and addiction medicine. We are utilizing our novel and proprietary BioErodible MucoAdhesive (BEMA®) and other drug delivery technologies to develop and commercialize, either on our own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs.

Upcoming Events
More events are coming soon.